Our January 2015 installment in the ongoing "New Frontiers in Prostate Cancer" series focuses on the challenges presented by high-risk disease. Here are some recommended articles about the diagnosis and treatment of high-risk prostate cancer.
Our January 2015 installment in the ongoing "New Frontiers in Prostate Cancer" series focuses on the challenges presented by high-risk disease. Here are some recommended articles about the diagnosis and treatment of high-risk prostate cancer.
“Cancer Treatment & Survivorship 2014-2015” (American Cancer Society)
Chang et al. High-risk prostate cancer-classification and therapy (Nat Rev Clin Oncol 2014; 11:308–23)
Lin et al. Radiation therapy for clinically node-positive prostate cancer and survival: results from the National Cancer Data Base (Int J Radiat Oncol Biol Phys 2014; 90:S13-14)
Cooperberg et al. Time trends and local variation in primary treatment of localized prostate cancer(J Clin Oncol 2010; 28:1117-23)
Daskivich et al. Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer (Cancer 2014; 120:3642-50)
Subscribe to Urology Times to get monthly news from the leading news source for urologists.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.